XML 67 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Collaboration Agreements (Ipsen Collaboration, Narrative) (Details)
$ in Millions, $ in Millions
3 Months Ended 12 Months Ended
Jan. 01, 2021
USD ($)
Oct. 02, 2020
USD ($)
Jul. 03, 2020
USD ($)
Apr. 03, 2020
USD ($)
Jan. 03, 2020
USD ($)
Sep. 27, 2019
USD ($)
Jun. 28, 2019
USD ($)
Mar. 29, 2019
USD ($)
Jan. 01, 2021
USD ($)
Jan. 03, 2020
USD ($)
Dec. 28, 2018
USD ($)
Dec. 31, 2016
USD ($)
Jan. 01, 2021
CAD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Milestone payments earned to date $ 350.0               $ 350.0        
Milestone payments earned 29.4 $ 13.5 $ 43.5 $ 0.1 $ 15.1 $ 50.6 $ 20.4 $ 10.0          
Remaining performance obligation 86.1               $ 86.1        
Collaborative Arrangement with GlaxoSmithKline                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Collaboration agreement percent of royalty on net sale                 3.00%        
Collaborative arrangement with Ipsen                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Collaboration period to achieve specified levels of commercial performance                 10 years        
Upfront payments                       $ 210.0  
Milestone payments earned                 $ 20.0 $ 55.0 $ 140.0    
Eligible payment from collaboration for development and regulatory milestone achievement under collaborations agreement 59.0               59.0        
Maximum amount eligible for commercial milestones under collaborations agreement 450.0               450.0       $ 26.5
Remaining performance obligation $ 41.3               $ 41.3        
Research and development arrangement performed for others, reimbursement for costs incurred, percent                 35.00%        
Collaborative arrangement with Ipsen | Minimum | Final tier                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Percent of royalty on net sale                 22.00%        
Collaborative arrangement with Ipsen | Maximum | Final tier                          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                          
Percent of royalty on net sale                 26.00%